Quantitative assessment of residual tumor is a strong and independent predictor of survival in methylated glioblastoma following radiochemotherapy with CCNU/TMZ.
Neuro-oncology
View this publicationNeuro-oncology
View this publicationVirchows Archiv : an international journal of pathology
View this publicationBrain and behavior
View this publicationThe Journal of comparative neurology
View this publicationProceedings of the National Academy of Sciences of the United States of America
View this publicationJournal of medicinal chemistry
View this publicationVaccine
View this publicationJournal of the American Heart Association
View this publicationThe Journal of infection
View this publicationJournal of cancer research and clinical oncology
View this publication